<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: types of cancer</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Stress contributes to cognitive declines in women with breast cancer, researcher says</title>
   	 <description>Women undergoing treatment for breast cancer can experience cognitive declines, such as decreased verbal fluency or loss of memory and attention. Often experienced by patients undergoing chemotherapy, the declines have become known as &quot;chemo brain.&quot; However, a health psychologist at the University of Missouri says &quot;chemo brain&quot; isn't always to blame.</description>
     <link>http://medicalxpress.com/news/2012-04-stress-contributes-cognitive-declines-women.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Wed, 11 Apr 2012 14:09:14 EST</pubDate>
	 <guid isPermaLink="false">news253372146</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/stresscontri.jpg" width="90" height="90" />
</item>
<item>
     <title>Harmless human virus may be able to boost the effects of chemotherapy</title>
   	 <description>A naturally-occurring harmless human virus may be able to boost the effects of two standard chemotherapy drugs in some cancer patients, according to early stage trial data published in Clinical Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-04-harmless-human-virus-boost-effects.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 16:53:50 EST</pubDate>
	 <guid isPermaLink="false">news252690820</guid>
	 
</item>
<item>
     <title>Researchers discover a DNA marker that indicates if ovarian cancer treatment will be successful</title>
   	 <description>Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered that blood can help determine the best treatment plan for patients with ovarian cancer. More specifically, a genetic marker embedded in deoxyribonucleic acid (DNA), called microRNA, indicates if a patient with ovarian cancer has a benign or cancerous tumor, and that she will benefit from chemotherapy after surgery on the tumor. This data will be presented at the American Association for Cancer Research (AACR) Annual Meeting to be held from Saturday through Wednesday (March 31- April 4) in Chicago, IL.</description>
     <link>http://medicalxpress.com/news/2012-04-dna-marker-ovarian-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 16:09:14 EST</pubDate>
	 <guid isPermaLink="false">news252688146</guid>
	 
</item>
<item>
     <title>Nearly half of cancer survivors died from conditions other than cancer</title>
   	 <description>Although cancer recurrence may be the overriding fear for many survivors, nearly half of survivors from a recently presented study died from other conditions.</description>
     <link>http://medicalxpress.com/news/2012-04-cancer-survivors-died-conditions.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 15:20:01 EST</pubDate>
	 <guid isPermaLink="false">news252684211</guid>
	 
</item>
<item>
     <title>Chemo may get boost from cholesterol-related drug</title>
   	 <description>Johns Hopkins investigators are testing a way to use drugs that target a cholesterol pathway to enhance the cancer-killing potential of standard chemotherapy drugs. Their tests, in mouse models of pancreatic cancer, may yield new and more effective combinations of current and possibly new anti-cancer drugs.</description>
     <link>http://medicalxpress.com/news/2012-04-chemo-boost-cholesterol-related-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 09:44:11 EST</pubDate>
	 <guid isPermaLink="false">news252665045</guid>
	 
</item>
<item>
     <title>Gene mapping for everyone? Study says not so fast</title>
   	 <description>Gene scans for everyone? Not so fast. New research suggests that for the average person, decoding your own DNA may not turn out to be a really useful crystal ball for future health.</description>
     <link>http://medicalxpress.com/news/2012-04-gene-fast.html</link>
	 <category>Genetics</category>
	 <pubDate>Mon, 02 Apr 2012 12:47:19 EST</pubDate>
	 <guid isPermaLink="false">news252589619</guid>
	 
</item>
<item>
     <title>Cancer treatment system sculpts radiation beam to match shape of a tumor</title>
   	 <description>Rush University Medical Center will begin offering in late March a new stereotactic radiosurgery treatment program with the latest radiation therapy technology available.</description>
     <link>http://medicalxpress.com/news/2012-03-cancer-treatment-sculpts-tumor.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 26 Mar 2012 11:45:32 EST</pubDate>
	 <guid isPermaLink="false">news251981123</guid>
	 
</item>
<item>
     <title>Study shows colorectal cancer screening rates high in patients with multiple health problems</title>
   	 <description>A study by University of Kentucky researchers showed that in Appalachia, colorectal cancer screening rates were higher in the population with multiple morbidities or diseases compared to those who had no morbidities at all.</description>
     <link>http://medicalxpress.com/news/2012-03-colorectal-cancer-screening-high-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 20 Mar 2012 15:52:38 EST</pubDate>
	 <guid isPermaLink="false">news251477520</guid>
	 
</item>
<item>
     <title>Study reveals new details about a protein that enables cancer cells to start new tumors in distant sites</title>
   	 <description>(Medical Xpress) -- A Loyola University Chicago Stritch School of Medicine study has revealed details of the complex molecular process involving a protein that enables cancer cells to establish tumors in distant parts of the body.</description>
     <link>http://medicalxpress.com/news/2012-03-reveals-protein-enables-cancer-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 14 Mar 2012 10:40:02 EST</pubDate>
	 <guid isPermaLink="false">news250939145</guid>
	 
</item>
<item>
     <title>Study reveals contraceptive cancer risks</title>
   	 <description>A study has revealed that injectable contraceptives that are widely used around the world influence the risk of developing several types of cancer.</description>
     <link>http://medicalxpress.com/news/2012-03-reveals-contraceptive-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 07 Mar 2012 08:50:01 EST</pubDate>
	 <guid isPermaLink="false">news250331426</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/2-studyreveals.jpg" width="90" height="90" />
</item>
<item>
     <title>Serotonin could play a large role in bone loss</title>
   	 <description>Scientists have long known that calcium leaches from the bones both during lactation and in certain types of cancer. The driver behind these phenomena is a molecule called parathyroid hormone related protein (PTHrP), which is secreted by the mammary glands. The signal that regulates the secretion of PTHrP, and where this other unknown molecule exerts its influence, has remained a mystery. Now, in a new study using cells and tissues from mice, cows, and people, a team of researchers at the University of Cincinnati have identified this mystery molecule as serotonin, a neurotransmitter most often recognized for its role in happiness and well-being. The scientists also identified the specific receptor that serotonin acts on in mammary tissue. Understanding these two findings more deeply could lead to better ways to combat bone loss, potentially by using drugs that affect serotonin signaling.</description>
     <link>http://medicalxpress.com/news/2012-02-serotonin-large-role-bone-loss.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 21 Feb 2012 13:00:01 EST</pubDate>
	 <guid isPermaLink="false">news249046859</guid>
	 
</item>
<item>
     <title>New blood test for early cancer detection developed</title>
   	 <description>A simple blood test is being developed by researchers at Ben-Gurion University of the Negev (BGU) and Soroka University Medical Center in Beer-Sheva, Israel that may provide early detection of many types of cancer.</description>
     <link>http://medicalxpress.com/news/2012-02-blood-early-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 21 Feb 2012 10:15:52 EST</pubDate>
	 <guid isPermaLink="false">news249041742</guid>
	 
</item>
<item>
     <title>Government panel favors some WTC cancer claims</title>
   	 <description>(AP) --  A government panel favors expanding an aid program for people sickened by World Trade Center dust to include people who have at least some types of cancer.</description>
     <link>http://medicalxpress.com/news/2012-02-panel-favors-wtc-cancer.html</link>
	 <category>Health</category>
	 <pubDate>Thu, 16 Feb 2012 14:40:01 EST</pubDate>
	 <guid isPermaLink="false">news248624251</guid>
	 
</item>
<item>
     <title>Potential treatment target for KRAS-mutated colon cancer found</title>
   	 <description>Researchers from the Massachusetts General Hospital (MGH) Cancer Center have identified a new potential strategy for treating colon tumors driven by mutations in the KRAS gene, which usually resist both conventional and targeted treatments. In a paper appearing in the Feb. 17 issue of Cell, the team reports that targeting a later step in the pathway leading from KRAS activation to tumor growth may be able to halt the process.</description>
     <link>http://medicalxpress.com/news/2012-02-potential-treatment-kras-mutated-colon-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 16 Feb 2012 12:00:20 EST</pubDate>
	 <guid isPermaLink="false">news248613313</guid>
	 
</item>
<item>
     <title>Researchers find important 'target' playing role in tobacco-related lung cancers</title>
   	 <description>Researchers at Moffitt Cancer Center in Tampa, Fla., have discovered that the immune response regulator IKBKE (serine/threonine kinase) plays two roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens induce IKBKE and, in turn, IKBKE induces chemotherapy resistance.</description>
     <link>http://medicalxpress.com/news/2012-02-important-role-tobacco-related-lung-cancers.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Feb 2012 12:55:37 EST</pubDate>
	 <guid isPermaLink="false">news248014519</guid>
	 
</item>
<item>
     <title>Gene linked to pancreatic cancer growth, study finds</title>
   	 <description>A mutant protein found in nearly all pancreatic cancers plays a role not only in the cancer's development but in its continued growth, according to a new study from University of Michigan Comprehensive Cancer Center researchers. The finding suggests a possible target for developing new ways to treat this deadly disease.</description>
     <link>http://medicalxpress.com/news/2012-01-gene-linked-pancreatic-cancer-growth.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 31 Jan 2012 11:08:43 EST</pubDate>
	 <guid isPermaLink="false">news247230516</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/genelinkedto.jpg" width="90" height="87" />
</item>
<item>
     <title>Compounds in mate tea induce death in colon cancer cells</title>
   	 <description>Could preventing colon cancer be as simple as developing a taste for yerba mate tea? In a recent University of Illinois study, scientists showed that human colon cancer cells die when they are exposed to the approximate number of bioactive compounds present in one cup of this brew, which has long been consumed in South America for its medicinal properties.</description>
     <link>http://medicalxpress.com/news/2012-01-compounds-tea-death-colon-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 23 Jan 2012 13:25:22 EST</pubDate>
	 <guid isPermaLink="false">news246547517</guid>
	 
</item>
<item>
     <title>Rigged to explode? Inherited mutation links exploding chromosomes to cancer</title>
   	 <description>An inherited mutation in a gene known as the guardian of the genome is likely the link between exploding chromosomes and some particularly aggressive types of cancer, scientists at the European Molecular Biology Laboratory (EMBL), the German Cancer Research Centre (DKFZ) and the University Hospital, all in Heidelberg, Germany, have discovered. Their study, published online today in Cell, also presents the first whole genome sequence of a paediatric tumour: medulloblastoma, a brain cancer which is the second most common cause of childhood mortality in developed countries, where only car accidents cause more deaths in children.</description>
     <link>http://medicalxpress.com/news/2012-01-rigged-inherited-mutation-links-chromosomes.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 19 Jan 2012 12:52:43 EST</pubDate>
	 <guid isPermaLink="false">news246199952</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/riggedtoexpl.jpg" width="90" height="90" />
</item>
<item>
     <title>Scientists find genetic key to why some cancer patients don't respond to treatment</title>
   	 <description>(Medical Xpress) -- Researchers from Newcastle University have identified a gene variation carried by 20% of the population which can significantly affect how patients with a rare type of blood cancer will respond to treatment.</description>
     <link>http://medicalxpress.com/news/2012-01-scientists-genetic-key-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 05 Jan 2012 09:20:01 EST</pubDate>
	 <guid isPermaLink="false">news244976719</guid>
	 
</item>
<item>
     <title>Cancer-killing compound spares healthy cells</title>
   	 <description>Lithocholic acid (LCA), naturally produced in the liver during digestion, has been seriously underestimated. A study published in the journal Oncotarget shows that LCA can kill several types of cancer cells, such as those found in some brain tumors and breast cancer.</description>
     <link>http://medicalxpress.com/news/2012-01-cancer-killing-compound-healthy-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 04 Jan 2012 12:22:53 EST</pubDate>
	 <guid isPermaLink="false">news244902162</guid>
	 
</item>
<item>
     <title>Ovarian cancer study proves drug delays disease progression, may improve survival</title>
   	 <description>Treating ovarian cancer with the drug bevacizumab (&quot;Avastin&quot;) delays the disease and may also improve survival, show the results of an international clinical trial co-led by Drs. Amit Oza of the Princess Margaret Cancer Program, University Health Network and Timothy Perren, St James's Institute of Oncology, Leeds, UK.</description>
     <link>http://medicalxpress.com/news/2011-12-ovarian-cancer-drug-disease-survival.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 28 Dec 2011 17:00:03 EST</pubDate>
	 <guid isPermaLink="false">news244293005</guid>
	 
</item>
<item>
     <title>Targeted therapy extends progression-free survival of patients with advanced ovarian cancer</title>
   	 <description>Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research suggests an additional avenue of treatment. The results of the trial appear in the December 29 issue of the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2011-12-therapy-progression-free-survival-patients-advanced.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 28 Dec 2011 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news244292529</guid>
	 
</item>
<item>
     <title>Some muscular dystrophy patients at increased risk for cancer</title>
   	 <description>People who have the most common type of adult muscular dystrophy also have a higher risk of getting cancer, according to a paper published today in the Journal of the American Medical Association.</description>
     <link>http://medicalxpress.com/news/2011-12-muscular-dystrophy-patients-cancer.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 13 Dec 2011 16:00:05 EST</pubDate>
	 <guid isPermaLink="false">news243004453</guid>
	 
</item>
<item>
     <title>Male cancer patients turn to alternative treatments</title>
   	 <description>(Medical Xpress) -- More than 50% of men diagnosed with cancer in Australia are turning to complementary and alternative medicine to help find a cure, or to improve their health, according to new research from the University of Adelaide.</description>
     <link>http://medicalxpress.com/news/2011-12-male-cancer-patients-alternative-treatments.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 13 Dec 2011 06:20:01 EST</pubDate>
	 <guid isPermaLink="false">news242978521</guid>
	 
</item>
<item>
     <title>Personalized treatment for Crohn's Disease a step closer following gene mapping</title>
   	 <description>Three new locations for Crohn's Disease genes have been uncovered by scientists at UCL using a novel gene mapping approach.</description>
     <link>http://medicalxpress.com/news/2011-12-personalized-treatment-crohn-disease-closer.html</link>
	 <category>Genetics</category>
	 <pubDate>Thu, 08 Dec 2011 12:57:06 EST</pubDate>
	 <guid isPermaLink="false">news242571383</guid>
	 
</item>
<item>
     <title>Acupuncture may ease severe nerve pain associated with cancer treatment</title>
   	 <description>Acupuncture may help ease the severe nerve pain associated with certain cancer drugs, suggests a small preliminary study published in Acupuncture in Medicine.</description>
     <link>http://medicalxpress.com/news/2011-12-acupuncture-ease-severe-nerve-pain.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 06 Dec 2011 04:40:03 EST</pubDate>
	 <guid isPermaLink="false">news242367516</guid>
	 
</item>
<item>
     <title>Tumor-specific pathway identified</title>
   	 <description>A research team led by UT Southwestern Medical Center scientists has identified an atypical metabolic pathway unique to some tumors, possibly providing a future target for drugs that could reduce or halt the spread of cancer.</description>
     <link>http://medicalxpress.com/news/2011-11-tumor-specific-pathway.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 22 Nov 2011 10:04:08 EST</pubDate>
	 <guid isPermaLink="false">news241178637</guid>
	 
</item>
<item>
     <title>Cancer vaccine impact limited unless drug industry focuses on difficult-to-treat tumors</title>
   	 <description>Drug companies currently developing therapeutic cancer vaccines may be determining the cancers they target based on the number of annual cases, not the number of deaths they cause.</description>
     <link>http://medicalxpress.com/news/2011-11-cancer-vaccine-impact-limited-drug.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 21 Nov 2011 16:38:09 EST</pubDate>
	 <guid isPermaLink="false">news241115880</guid>
	 
</item>
<item>
     <title>Class of breast cancer drugs could treat other types of cancer</title>
   	 <description>(Medical Xpress) -- A class of drugs used to treat breast cancers which overproduce a protein called HER2 could also treat other types of cancer &amp;#150; particularly head and neck cancers, according to research presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week.</description>
     <link>http://medicalxpress.com/news/2011-11-class-breast-cancer-drugs.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 09 Nov 2011 07:27:23 EST</pubDate>
	 <guid isPermaLink="false">news240046034</guid>
	 
</item>
<item>
     <title>Why measles spreads so quickly</title>
   	 <description>Mayo Clinic researchers have discovered why measles, perhaps the most contagious viral disease in the world, spreads so quickly. The virus emerges in the trachea of its host, provoking a cough that fills the air with particles ready to infect the next host. The findings may also help in the fight against ovarian, breast and lung cancers.</description>
     <link>http://medicalxpress.com/news/2011-11-measles-quickly.html</link>
	 <category>Medical research</category>
	 <pubDate>Wed, 02 Nov 2011 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news239461145</guid>
	 
</item>


</channel>
</rss>
